A 20-year-old, fully independent Mohs surgery and medical dermatology practice in coastal southeastern Connecticut is available for acquisition. Offered at $4,400,000 — approximately 2.3x a normalized Seller’s Discretionary Earnings (SDE) of $1,887,364 (the four-year average SDE adjusted for 3% 2026 growth).
This is a direct-to-physician opportunity — not structured for private equity, MSOs, or financial acquirers. The ideal buyer is a fellowship-trained Mohs surgeon or board-certified dermatologist ready to own and operate an established, fully operational practice in one of coastal New England’s most desirable communities. A board-certified dermatologist who is not personally Mohs-fellowship-trained may also acquire the practice, provided they employ a fellowship-trained Mohs surgeon to perform the Mohs caseload.
KEY METRICS:
- Asking Price: $4,400,000 (~2.3x normalized SDE)
- Normalized SDE: $1,887,364 (4-yr avg + 3% growth)
- $4,000,000 cash at close; $400,000 seller financing for qualified physician buyers
- 16,820 annual encounters | 11,150 established patients | 1,000–1,200 Mohs cases/yr
- Avg base collections/encounter: $398 | Payer mix: 62% Medicare, 34% commercial — no Medicaid
- Google rating: 4.7 / 5.0 | Founded 2006
2025 REVENUE NOTE:
2025 included a non-recurring skin-substitute (placental allograft) revenue stream the practice is discontinuing in 2026 due to Medicare reimbursement changes. The valuation deliberately normalizes this out; buyers should model from normalized SDE, not 2025 reported figures. Full detail provided under NDA.
WHAT YOU’RE ACQUIRING:
Three experienced providers — a fourth joining mid-2026 — all expected to remain post-sale. PA-Cs generate 55–60% of base net collections through medical dermatology, biopsies, and procedures, feeding Mohs cases directly to the physician-owner. This built-in referral engine reduces key-person risk and supports a full schedule from day one. Full procedural breadth: Mohs micrographic surgery, CLIA-certified in-office histopathology lab, excisions, biopsies, cryotherapy, allergy patch testing, SRT, ALA photodynamic therapy, and cosmetic Botox. The incoming physician steps into a complete clinical infrastructure — no build phase, no rebranding, no stabilization period.
FINANCING: Conventional medical practice financing at competitive rates (currently sub-6%, 15-year amortization) for qualified physician buyers; SBA 7(a) also available; $400,000 seller financing.
